Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexmedetomidine for prevention of postoperative delirium in critically ill elderly patients after noncardiac surgery
ChiCTR-TRC-10000802Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Placebo group with Dexmedetomidine group (2 arms). Primary endpoint: Incidence of postoperative delirium within the first seven days after surgery. Started Aug 2011; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR-TRC-10000802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000802.